Disease · MONDO_0005642

Comparisons in its trials19

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 19 of 19

Download this page as JSON

Comparison	Group 1, with the outcome	Group 2, with the outcome	Participants	Trial	Source
Alrex vs Patanol: serious adverse events	1 of 151	0 of 149	300	NCT01435460	Trial comparisons
Bepotastine Besilate Ophthalmic Solution vs Placebo: deaths from any cause	0 of 123	0 of 121	244	NCT01174823	Trial comparisons
Bepotastine Besilate Ophthalmic Solution vs Placebo: serious adverse events	0 of 123	1 of 121	244	NCT01174823	Trial comparisons
Olopatadine 0.1% vs Epinastine 0.05%: serious adverse events	0 of 50	0 of 50	100	NCT02251613	Trial comparisons
NS2 Ophthalmic Drops (0.5%) vs Vehicle Ophthalmic Drops: deaths from any cause	0 of 50	0 of 50	100	NCT02578914	Trial comparisons
NS2 Ophthalmic Drops (0.5%) vs Vehicle Ophthalmic Drops: serious adverse events	0 of 50	0 of 50	100	NCT02578914	Trial comparisons
OTX-DP vs Placebo: deaths from any cause	0 of 48	0 of 48	96	NCT04050865	Trial comparisons
OTX-DP vs Placebo: serious adverse events	0 of 48	0 of 48	96	NCT04050865	Trial comparisons
OTX-DP vs Placebo Vehicle: deaths from any cause	0 of 41	0 of 40	81	NCT02988882	Trial comparisons
OTX-DP vs Placebo Vehicle: serious adverse events	0 of 41	0 of 40	81	NCT02988882	Trial comparisons
OTX-DP vs Placebo Vehicle: deaths from any cause	0 of 35	0 of 38	73	NCT02445326	Trial comparisons
OTX-DP vs Placebo Vehicle: serious adverse events	0 of 35	0 of 38	73	NCT02445326	Trial comparisons
OTX-DP Treatment vs Placebo Plug Delivery Vehicle: serious adverse events	1 of 31	0 of 33	64	NCT02062905	Trial comparisons
Refresh Tears® Eye Drops vs Bepreve® 1.5% Solution: serious adverse events	0 of 20	0 of 20	40	NCT01346371	Trial comparisons
Dexamethasone Insert vs Loteprednol Etabonate Ophthalmic Gel 0.38%: deaths from any cause	0 of 18	0 of 18	36	NCT04418999	Trial comparisons
Dexamethasone Insert vs Loteprednol Etabonate Ophthalmic Gel 0.38%: serious adverse events	0 of 18	0 of 18	36	NCT04418999	Trial comparisons
Bepreve vs Alrex: serious adverse events	0 of 12	0 of 11	23	NCT01443442	Trial comparisons
Prednisolone vs Placebo: deaths from any cause	0 of 5	0 of 6	11	NCT01534195	Trial comparisons
Prednisolone vs Placebo: serious adverse events	0 of 5	0 of 6	11	NCT01534195	Trial comparisons

diseases-2026-09-18-0.1.0

Sources 6

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005642/comparisons

API reference For AI assistants